Clarity Genomics in the News

 

Clarity Genomics joins Johnson & Johnson’s JLINX

The JLINX incubator will help Clarity Genomics develop a platform that learns how human microbiome communities interact with the host.  This is done through analysis of genetic, functional and metabolic data. Clarity applies this knowledge to facilitate biomarker discovery and patient stratification for better healthcare.

 

Clarity Genomics is one of the first startups on Johnson & Johnson’s JLABS incubator in Belgium

There are already a handful of innovative medical and health startups on the site, including Clarity Genomics which focuses on microbiome analysis in clinical trials.

 

Rayan Chikhi, Advisor to Clarity Genomics, Scores Highest in the Assembly Category for the Strain Community Challenge hosted by DNAnexus-Powered Mosaic Microbiome Platform 

“Being able to see results in real time through this Challenge was a game changer, allowing us to look across the community to improve our methods of analysis in near, real time.” –  Rayan Chikhi, Ph.D., CNRS and CRIStAL research center, and an advisor at Clarity Genomics.

“Profiling a microbiome sample is the fundamental step in any microbiome analysis and an essential part of biotherapeutic drug development” – Richard Daly, Chief Executive Officer of DNAnexus.